{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:50:25Z","timestamp":1768470625594,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01-CA059827"],"award-info":[{"award-number":["P01-CA059827"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA132834"],"award-info":[{"award-number":["R01-CA132834"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ijrobp.2017.10.005","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T00:32:03Z","timestamp":1515371523000},"page":"335-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Modeling of Normal Tissue Complications Using Imaging and Biomarkers After Radiation Therapy for Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"100","author":[{"given":"Issam","family":"El Naqa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9849-2143","authenticated-orcid":false,"given":"Adam","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Matuszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latifa","family":"Bazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore S.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall K.","family":"Ten Haken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.10.005_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1593\/tlo.12448","article-title":"Stereotactic body radiation therapy for primary and metastatic liver tumors","volume":"6","author":"Liu","year":"2013","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","article-title":"Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies","volume":"78","author":"Goodman","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cncr.29161","article-title":"Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma","volume":"121","author":"Herman","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib5","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1200\/JCO.2014.55.4675","article-title":"Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice","volume":"32","author":"Timmerman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib6","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.ijrobp.2017.10.005_bib7","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib8","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ijrobp.2005.01.002","article-title":"A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases","volume":"62","author":"Schefter","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib9","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","article-title":"Phase I study of individualized stereotactic body radiotherapy of liver metastases","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12094-010-0492-x","article-title":"Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma","volume":"12","author":"C\u00e1rdenes","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ijrobp.2009.09.009","article-title":"Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: Dose-volumetric parameters predicting the hepatic complication","volume":"78","author":"Son","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib13","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/j.ijrobp.2011.04.011","article-title":"Stereotactic body radiotherapy for primary hepatocellular carcinoma","volume":"81","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib15","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0360-3016(94)00471-4","article-title":"Analysis of clinical complication data for radiation hepatitis using a parallel architecture model","volume":"31","author":"Jackson","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib17","series-title":"CTCAE Version 4.0","year":"2010"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach\u2014The ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00534-004-0965-9","article-title":"Assessment of hepatic reserve for indication of hepatic resection: Decision tree incorporating indocyanine green test","volume":"12","author":"Imamura","year":"2005","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.radonc.2014.04.007","article-title":"Estimating functional liver reserve following hepatic irradiation: Adaptive normal tissue response models","volume":"111","author":"Stenmark","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.04.035","article-title":"Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy","volume":"73","author":"Lee","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijrobp.2017.01.221","article-title":"Predictors of liver toxicity following stereotactic body radiation therapy for hepatocellular carcinoma","volume":"97","author":"Velec","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1667\/RR3031.1","article-title":"Cytokines in radiobiological responses: A review","volume":"178","author":"Schaue","year":"2012","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semradonc.2011.05.003","article-title":"Hepatic radiation toxicity: Avoidance and amelioration","volume":"21","author":"Guha","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2007.05.078","article-title":"Liver function after irradiation based on computed tomographic portal vein perfusion imaging","volume":"70","author":"Cao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijrobp.2015.09.044","article-title":"Local and global function model of the liver","volume":"94","author":"Wang","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijrobp.2012.02.037","article-title":"Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging","volume":"85","author":"Cao","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02990026","article-title":"Comparison of Tc-99m-GSA scintigraphy with hepatic fibrosis and regeneration in patients with hepatectomy","volume":"17","author":"Iguchi","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ijrobp.2013.04.007","article-title":"Predictive models for regional hepatic function based upon 99mTc-IDA SPECT and local radiation dose for physiological adaptive RT","volume":"86","author":"Wang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11604-012-0072-9","article-title":"A quantitative index measured on 99mTc GSA SPECT\/CT 3D fused images to evaluate severe fibrosis in patients with chronic liver disease","volume":"30","author":"Yoshida","year":"2012","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib31","series-title":"Radiation Therapy for Liver Tumors: Fundamentals and Clinical Practice","article-title":"Radiation sensitivity of the liver: Models and clinical data","author":"El Naqa","year":"2017"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijrobp.2005.11.034","article-title":"Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma","volume":"65","author":"Xu","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib33","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ijrobp.2011.03.056","article-title":"The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer","volume":"82","author":"Defraene","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.radonc.2011.06.032","article-title":"Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer","volume":"100","author":"Rancati","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2015.03.005","article-title":"Contrasting analytical and data-driven frameworks for radiogenomic modeling of normal tissue toxicities in prostate cancer","volume":"115","author":"Coates","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijrobp.2012.02.021","article-title":"Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis","volume":"85","author":"Tucker","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib37","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1118\/1.2969065","article-title":"Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation","volume":"35","author":"Astrahan","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.18383\/j.tom.2016.00145","article-title":"An overdetermined system of transform equations in support of robust DCE-MRI registration with outlier rejection","volume":"2","author":"Johansson","year":"2016","journal-title":"Tomography"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib39","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1088\/0031-9155\/57\/17\/5601","article-title":"GPU-accelerated voxelwise hepatic perfusion quantification","volume":"57","author":"Wang","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","article-title":"A threshold selection method from gray-level histograms","volume":"9","author":"Otsu","year":"1979","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2307\/3577586","article-title":"Transforming growth factor-\u03b21 expression in irradiated liver","volume":"122","author":"Anscher","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib42","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1440-1746.2006.04621.x","article-title":"Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course","volume":"22","author":"Tacke","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib43","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1210\/en.2004-0655","article-title":"Role of growth hormone (GH) in liver regeneration","volume":"145","author":"Pennisi","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib44","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/clin.1998.4606","article-title":"Blockade of CD40\u2013CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis","volume":"89","author":"Adawi","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-8140(02)00061-0","article-title":"Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: Clinical manifestation and dosimetric description","volume":"63","author":"Cheng","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib46","first-page":"119","article-title":"Approximate is better than \u201cexact\u201d for interval estimation of binomial proportiions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Stat"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib47","series-title":"Generalized Linear Models","author":"McCullagh","year":"1998"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib49","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1088\/0031-9155\/61\/17\/6465","article-title":"Optimizing global liver function in radiation therapy treatment planning","volume":"61","author":"Wu","year":"2016","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2017.10.005_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell Mol Immunol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617339676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617339676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T23:01:09Z","timestamp":1660258869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301617339676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0360301617339676"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.10.005","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling of Normal Tissue Complications Using Imaging and Biomarkers After Radiation Therapy for Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}